Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Separation and determination of alpha-synuclein monomeric and oligomeric species using two electrophoretic approaches.

Napp A, Houbart V, Demelenne A, Merville MP, Crommen J, Dumoulin M, Garraux G, Servais AC, Fillet M.

Electrophoresis. 2018 Dec;39(23):3022-3031. doi: 10.1002/elps.201800224. Epub 2018 Sep 13.

PMID:
30157293
2.

Correlation between deep brain stimulation effects on freezing of gait and audio-spinal reflex.

Parmentier É, De Pasqua V, D'Ostilio K, Depierreux F, Garraux G, Maertens de Noordhout A.

Clin Neurophysiol. 2018 Oct;129(10):2083-2088. doi: 10.1016/j.clinph.2018.07.006. Epub 2018 Jul 21.

PMID:
30077869
3.

Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism.

Segovia F, Górriz JM, Ramírez J, Martínez-Murcia FJ, Levin J, Schuberth M, Brendel M, Rominger A, Bötzel K, Garraux G, Phillips C.

Front Neuroinform. 2017 Mar 30;11:23. doi: 10.3389/fninf.2017.00023. eCollection 2017.

4.

Comparative assessment of 6-[18 F]fluoro-L-m-tyrosine and 6-[18 F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model.

Becker G, Bahri MA, Michel A, Hustadt F, Garraux G, Luxen A, Lemaire C, Plenevaux A.

J Neurochem. 2017 May;141(4):626-635. doi: 10.1111/jnc.14016. Epub 2017 Apr 12.

5.

Data set of healthy old people assessed for three walking conditions using accelerometric and opto-electronic methods.

Gillain S, Boutaayamou M, Dardenne N, Schwartz C, Demonceau M, Gerontitis C, Depierreux F, Salmon E, Garraux G, Bruyère O, Brüls O, Croisier JL, Petermans J.

Aging Clin Exp Res. 2017 Dec;29(6):1201-1209. doi: 10.1007/s40520-017-0730-y. Epub 2017 Feb 28.

6.

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.

Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, Crosiers D, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium.

Neurobiol Aging. 2017 Jan;49:217.e1-217.e4. doi: 10.1016/j.neurobiolaging.2016.09.022. Epub 2016 Oct 6.

7.

Contribution of four lifelong factors of cognitive reserve on late cognition in normal aging and Parkinson's disease.

Rouillard M, Audiffren M, Albinet C, Ali Bahri M, Garraux G, Collette F.

J Clin Exp Neuropsychol. 2017 Mar;39(2):142-162. doi: 10.1080/13803395.2016.1207755. Epub 2016 Aug 12.

PMID:
27686164
8.

Effects of twelve weeks of aerobic or strength training in addition to standard care in Parkinson's disease: a controlled study.

Demonceau M, Maquet D, Jidovtseff B, Donneau AF, Bury T, Croisier JL, Crielaard JM, Rodriguez de la Cruz C, Delvaux V, Garraux G.

Eur J Phys Rehabil Med. 2017 Apr;53(2):184-200. doi: 10.23736/S1973-9087.16.04272-6. Epub 2016 Sep 1.

9.

The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease.

D'Ostilio K, Garraux G.

Front Hum Neurosci. 2016 Apr 22;10:161. doi: 10.3389/fnhum.2016.00161. eCollection 2016. Review.

10.

Effects of 10 Hz and 20 Hz Transcranial Alternating Current Stimulation on Automatic Motor Control.

Cappon D, D'Ostilio K, Garraux G, Rothwell J, Bisiacchi P.

Brain Stimul. 2016 Jul-Aug;9(4):518-24. doi: 10.1016/j.brs.2016.01.001. Epub 2016 Mar 18.

PMID:
27038707
11.

Comment on: Hemidystonia caused by frontal cortical infarction.

Garraux G.

Acta Neurol Belg. 2016 Mar;116(1):115. doi: 10.1007/s13760-015-0557-2. Epub 2015 Nov 25. No abstract available.

12.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

13.

Contribution of a Trunk Accelerometer System to the Characterization of Gait in Patients With Mild-to-Moderate Parkinson's Disease.

Demonceau M, Donneau AF, Croisier JL, Skawiniak E, Boutaayamou M, Maquet D, Garraux G.

IEEE J Biomed Health Inform. 2015 Nov;19(6):1803-8. doi: 10.1109/JBHI.2015.2469540. Epub 2015 Aug 19.

PMID:
26292350
14.

Development and validation of an accelerometer-based method for quantifying gait events.

Boutaayamou M, Schwartz C, Stamatakis J, Denoël V, Maquet D, Forthomme B, Croisier JL, Macq B, Verly JG, Garraux G, Brüls O.

Med Eng Phys. 2015 Feb;37(2):226-32. doi: 10.1016/j.medengphy.2015.01.001. Epub 2015 Jan 21.

15.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium.

Neurology. 2014 Nov 18;83(21):1906-13. doi: 10.1212/WNL.0000000000001012. Epub 2014 Oct 17.

16.

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease.

Ziegler E, Rouillard M, André E, Coolen T, Stender J, Balteau E, Phillips C, Garraux G.

Neuroimage. 2014 Oct 1;99:498-508. doi: 10.1016/j.neuroimage.2014.06.033. Epub 2014 Jun 20.

17.

Biased binomial assessment of cross-validated estimation of classification accuracies illustrated in diagnosis predictions.

Noirhomme Q, Lesenfants D, Gomez F, Soddu A, Schrouff J, Garraux G, Luxen A, Phillips C, Laureys S.

Neuroimage Clin. 2014 Apr 13;4:687-94. doi: 10.1016/j.nicl.2014.04.004. eCollection 2014.

18.

Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.

Garraux G, Phillips C, Schrouff J, Kreisler A, Lemaire C, Degueldre C, Delcour C, Hustinx R, Luxen A, Destée A, Salmon E.

Neuroimage Clin. 2013 Jun 14;2:883-93. doi: 10.1016/j.nicl.2013.06.004. eCollection 2013.

19.

[Impulse control behaviors associated with antiparkinsonian medications].

Depierreux-Lahaye F, Crémers J, Skawiniak E, Parmentier E, Delvaux V, Garraux G.

Rev Med Liege. 2013 May-Jun;68(5-6):221-5. French.

20.

Impaired automatic and unconscious motor processes in Parkinson's disease.

D'Ostilio K, Cremers J, Delvaux V, Sadzot B, Garraux G.

Sci Rep. 2013;3:2095. doi: 10.1038/srep02095.

Supplemental Content

Loading ...
Support Center